Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome

C. Michel Harper, Andrew G. Engel

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	203-206
Number of pages	4
Journal	Annals of the New York Academy of Sciences
Volume	841
DOIs	https://doi.org/10.1111/j.1749-6632.1998.tb10929.x
State	Published - 1998

ASJC Scopus subject areas

@article{b647e7c48f774219ae8bd0a3a23260fc,

title = "Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome",

author = "Harper, {C. Michel} and Engel, {Andrew G.}",

year = "1998",

doi = "10.1111/j.1749-6632.1998.tb10929.x",

language = "English (US)",

volume = "841",

pages = "203--206",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome

AU - Harper, C. Michel

AU - Engel, Andrew G.

PY - 1998

Y1 - 1998

UR - http://www.scopus.com/inward/record.url?scp=0031927397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031927397&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.1998.tb10929.x

DO - 10.1111/j.1749-6632.1998.tb10929.x

M3 - Article

C2 - 9668241

AN - SCOPUS:0031927397

SN - 0077-8923

VL - 841

SP - 203

EP - 206

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

ER -